JP2016514143A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016514143A5 JP2016514143A5 JP2016501594A JP2016501594A JP2016514143A5 JP 2016514143 A5 JP2016514143 A5 JP 2016514143A5 JP 2016501594 A JP2016501594 A JP 2016501594A JP 2016501594 A JP2016501594 A JP 2016501594A JP 2016514143 A5 JP2016514143 A5 JP 2016514143A5
- Authority
- JP
- Japan
- Prior art keywords
- nutritional supplement
- tetrandrine
- tetrandrine family
- drug
- structural formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361793028P | 2013-03-15 | 2013-03-15 | |
| US61/793,028 | 2013-03-15 | ||
| PCT/US2014/024649 WO2014150959A2 (en) | 2013-03-15 | 2014-03-12 | Method and products for enhancing cellular uptake of drug and dietary supplements |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016514143A JP2016514143A (ja) | 2016-05-19 |
| JP2016514143A5 true JP2016514143A5 (https=) | 2017-05-18 |
Family
ID=51529978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016501594A Pending JP2016514143A (ja) | 2013-03-15 | 2014-03-12 | 薬物及び栄養補助剤の細胞取り込みを高める方法及び生成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9254323B2 (https=) |
| EP (1) | EP3038655A4 (https=) |
| JP (1) | JP2016514143A (https=) |
| KR (1) | KR20150141970A (https=) |
| CN (1) | CN105377259A (https=) |
| MX (1) | MX2015013160A (https=) |
| WO (1) | WO2014150959A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105357966A (zh) * | 2013-03-15 | 2016-02-24 | Cba制药公司 | 提高药物和膳食补充剂的生物利用度的方法和产品 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5332747A (en) | 1989-09-28 | 1994-07-26 | Cancer Biologics Of America, Inc. | Method for potentiating primary drugs in treating multidrug resistant parasitic disease cells |
| US6911454B1 (en) | 1989-09-28 | 2005-06-28 | Cancer Biologics Of America, Inc. | Method for potentiating primary drugs in treating multidrug resistant disease |
| AU673142B2 (en) | 1991-04-19 | 1996-10-31 | Cba International, Inc. | Method for potentiating primary drugs in treating multidrug resistant cells |
| US6086915A (en) * | 1998-04-01 | 2000-07-11 | Bioresponse L.L.C. | Compositions and methods of adjusting steroid hormone metabolism through phytochemicals |
| US6350476B1 (en) | 2000-05-22 | 2002-02-26 | Shanxi Zhengzhon Pharmaceutical Co., Ltd. | Herbal chinese joint complex |
| CN102600159A (zh) * | 2012-03-09 | 2012-07-25 | 深圳松乐生物科技有限公司 | 含有粉防己碱及粉防己碱类衍生物和氟喹诺酮类药物的组合物及其应用 |
| WO2014043347A1 (en) * | 2012-09-13 | 2014-03-20 | Cba Pharma, Inc. | Mdr method and products for treating mrsa |
| CN105357966A (zh) * | 2013-03-15 | 2016-02-24 | Cba制药公司 | 提高药物和膳食补充剂的生物利用度的方法和产品 |
-
2014
- 2014-03-12 MX MX2015013160A patent/MX2015013160A/es unknown
- 2014-03-12 JP JP2016501594A patent/JP2016514143A/ja active Pending
- 2014-03-12 US US14/206,739 patent/US9254323B2/en active Active
- 2014-03-12 EP EP14770474.6A patent/EP3038655A4/en not_active Withdrawn
- 2014-03-12 CN CN201480028295.1A patent/CN105377259A/zh active Pending
- 2014-03-12 KR KR1020157029674A patent/KR20150141970A/ko not_active Ceased
- 2014-03-12 WO PCT/US2014/024649 patent/WO2014150959A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2018114447A (ru) | Введение дейтерированных усилителей cftr | |
| JP2015500225A5 (https=) | ||
| HRP20191617T1 (hr) | Kombinacija koja sadrži inhibitor mek i inhibitor b-raf | |
| RU2014141362A (ru) | Комбинированная терапия пролиферативных нарушений | |
| JP2012193216A5 (https=) | ||
| JP2016040288A5 (https=) | ||
| JP2016515628A5 (https=) | ||
| EA201300420A1 (ru) | Комбинации, которые содержат замещенный n-(2-ариламино) арилсульфонамид | |
| JP2017513809A5 (https=) | ||
| RU2017106172A (ru) | Применение антагонистов cxcr2 для предотвращения и/или лечения периферической невропатии, вызванной химиотерапией (cipn) | |
| JP2015522033A5 (https=) | ||
| JP2017511377A5 (https=) | ||
| EA201691918A1 (ru) | Фармацевтические составы ингибитора киназ семейства raf, способы их получения и способы их применения | |
| JP2019532047A5 (https=) | ||
| RU2014117707A (ru) | Способ лечения пролиферативного заболевания | |
| EA201791147A1 (ru) | Фармацевтическая композиция, ее получение и применения | |
| EA201791138A1 (ru) | Фармацевтическая композиция, ее приготовление и применения | |
| JP2020523375A5 (https=) | ||
| RU2017127509A (ru) | Композиции и способы для улучшенного мышечного метаболизма | |
| JP2014148552A5 (https=) | ||
| JP2019513828A5 (https=) | ||
| JP2016531853A5 (https=) | ||
| JP2019515033A5 (https=) | ||
| JP2016514142A5 (https=) | ||
| JP2016514143A5 (https=) |